Skip to main content
. 2005 Oct 3;202(7):975–986. doi: 10.1084/jem.20050421

Figure 7.

Figure 7.

Disruption of the macromolecular complex of LPA2-NHERF2–CFTR using a LPA2-specific peptide prevents LPA2-mediated CFTR inhibition by LPA. (A) Isc in response to ADO in HT29-CL19A cells with or without LPA2-specific peptide delivered before Isc measurement. Cells in both groups were pretreated with LPA 20:4 (25 μM) for 30 min before activating with ADO. (B) Immunofluorescence micrographs of HT29-CL19A cells from (A) showing the LPA2-specific peptide delivered (top; green). The nucleus was stained with propidium iodide (red). HT29-CL19A cells express endogenous LPA2 (bottom). (C) NHERF2 binding to LPA2 in the presence of LPA2-specific peptide. A curve showing the averaged band density also is presented. *P < 0.05; **P < 0.01 compared with control (n = 3).